GEN3017 / Genmab  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GEN3017 / Genmab
NCT06018129: A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Recruiting
1/2
240
US, RoW
GEN3017, DuoBody® CD3xCD30
Genmab
Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma
12/29
12/32

Download Options